Nephros
NEPH
18 hedge funds and large institutions have $9.4M invested in Nephros in 2024 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 3 closing their positions.
167% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 3
0% more funds holding
Funds holding: 18 → 18 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
1.16% less ownership
Funds ownership: 41.62% → 40.46% (-1.2%)
38% less capital invested
Capital invested by funds: $15.1M → $9.4M (-$5.7M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$131K |
| 2 |
TSS
Two Sigma Securities
New York
|
+$36.8K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$13.8K |
| 4 |
EP
Elkhorn Partners
Omaha,
Nebraska
|
+$13K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$6.05K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WC
Wexford Capital
West Palm Beach,
Florida
|
-$261K |
| 2 |
Morgan Stanley
New York
|
-$197K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$40.7K |
| 4 |
BA
Bard Associates
Chicago,
Illinois
|
-$25.2K |
| 5 |
BlackRock
New York
|
-$14.3K |
NEPH Hedge Fund Activity: Q1 2024 in Review
18 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Nephros (NEPH) for Q1 2024, worth a combined $9.4M — down 38% from $15.1M a quarter earlier.
Fund positioning in NEPH was balanced in Q1 2024: 3 funds opened new positions, 3 closed out, 8 added to existing stakes and 3 trimmed.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $131K. The largest seller was Wexford Capital, cutting an estimated $261K.
- 18 institutional investors held Nephros (NEPH) as of Q1 2024, unchanged from Q4 2023.
- Funds reported $9.4M of Nephros stock for Q1 2024, down 38% quarter-over-quarter.
- 3 funds opened new Nephros positions in Q1 2024 and 3 closed out, a net change of 0 holders.
- The largest Nephros buyer in Q1 2024 was Renaissance Technologies, an estimated $131K added.
- The largest Nephros seller in Q1 2024 was Wexford Capital, an estimated $261K sold.
Based on aggregated 13F filings for Q1 2024.